A successful COVID-19 vaccine will need to protect those who are 65 or older, one of our most vulnerable populations.
3 min read
8 min read
We’re bombarded every day with news about the latest miracle vaccine candidate: when it will be available, which vaccines have reached clinical trials, the stock market performance of the manufacturers, and so on.
4 min read
The race is on. Across the globe, researchers, scientists and CEOs are developing more than 160 vaccines, all taking aim at COVID-19.
13 min read
In the age of COVID, how do you 10X your business? And more broadly, in the coming decade, how do you go from a linear ‘old-school’ company to an ‘Exponential Organization’? Today, there is a clear strategy…